Literature DB >> 19479836

Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree.

Frank T Saulsbury1, Carine H Wouters, Tammy M Martin, Carrie R Austin, Trudy M Doyle, Kelly A Goodwin, Carlos D Rosé.   

Abstract

Pediatric granulomatous arthritis (PGA) has been associated with 12 different substitutions in the NOD2 gene thus far. We report a case of PGA in a 6-year-old girl with the NOD2 E383K gene substitution. Genotype analysis of the patient's family members revealed that her affected paternal aunt, as well as her asymptomatic father and 3 younger siblings, were heterozygous for the E383K substitution. The patient's mother did not have a NOD2 mutation. This is the first report of a pedigree in which 4 asymptomatic members carry the E383K substitution in NOD2, as well as the first observation of an asymptomatic carrier state for any of the NOD2 "Blau mutations."

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479836     DOI: 10.1002/art.24532

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

Review 1.  Distinguishing Blau Syndrome from Systemic Sarcoidosis.

Authors:  Katherine P Kaufman; Mara L Becker
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

Review 2.  Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis.

Authors:  Cailin Henderson; Raphaela Goldbach-Mansky
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

Review 3.  Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: NOD2, PLCG2 and LACC1.

Authors:  Ann Marie Szymanski; Michael J Ombrello
Journal:  Int Immunol       Date:  2018-04-25       Impact factor: 4.823

4.  Potential Composite Digenic Contribution of NPC1 and NOD2 Leading to Atypical Lethal Niemann-Pick Type C with Initial Crohn's Disease-like Presentation: Genotype-Phenotype Correlation Study.

Authors:  Bilal Azab; Omar Rabab'h; Dunia Aburizeg; Hashim Mohammad; Zain Dardas; Lina Mustafa; Ruba A Khasawneh; Heyam Awad; Ma'mon M Hatmal; Eyad Altamimi
Journal:  Genes (Basel)       Date:  2022-05-29       Impact factor: 4.141

Review 5.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

6.  Blau Syndrome and Early-Onset Sarcoidosis: A Six Case Series and Review of the Literature.

Authors:  Ayşenur PaÇ Kisaarslan; Betül SÖzerİ; Nihal Şahİn; Sümeyra Özdemİr ÇİÇek; Zübeyde GÜndÜz; Erkan Demİrkaya; Afig Berdelİ; Serdal Sadet Özcan; Hakan PorazoĞlu; Ruhan DÜŞÜnsel
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

7.  Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency.

Authors:  Zuzana Parackova; Marketa Bloomfield; Petra Vrabcova; Irena Zentsova; Adam Klocperk; Tomas Milota; Michael Svaton; Jean-Laurent Casanova; Jacinta Bustamante; Eva Fronkova; Anna Sediva
Journal:  J Clin Immunol       Date:  2019-11-23       Impact factor: 8.542

Review 8.  Blau syndrome, the prototypic auto-inflammatory granulomatous disease.

Authors:  Carine H Wouters; Anne Maes; Kevin P Foley; John Bertin; Carlos D Rose
Journal:  Pediatr Rheumatol Online J       Date:  2014-08-06       Impact factor: 3.054

9.  Blau syndrome: Lessons learned in a tertiary care centre at Chandigarh, North India.

Authors:  Rajni Kumrah; Rakesh Kumar Pilania; Nitin Kumar Menia; Amit Rawat; Jyoti Sharma; Anju Gupta; Pandiarajan Vignesh; Ankur Kumar Jindal; Rashmi Rikhi; Aniruddha Agarwal; Vishali Gupta; Surjit Singh; Deepti Suri
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

10.  Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome.

Authors:  Shao-Yu Chang; Naotomo Kambe; Wen-Lang Fan; Jing-Long Huang; Wen-I Lee; Chao-Yi Wu
Journal:  Pediatr Rheumatol Online J       Date:  2022-10-03       Impact factor: 3.413

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.